Table 1.
TA (n = 19) | Placebo (n = 19) | P-Value | |
Age (y) | 55 ± 11 | 60 ± 7 | 0.17 |
M/F | 18/1 | 18/1 | 1.0 |
Wt. (Kg) | 73 ± 15 | 71 ± 14 | 0.74 |
BMI | 27 ± 4 | 27 ± 4 | 1.0 |
Smoking | 6 (31.5%) | 6 (31.5%) | 1.0 |
Diabetes | 7 (37%) | 10 (53%) | 0.42 |
Hypertension | 7 (37%) | 12 (63%) | 0.17 |
Hyperchol | 3 (16%) | 0 (0%) | 0.08 |
COPD | 1 (5%) | 1 (5%) | 1.0 |
RF | 0 (0%) | 1 (5%) | 0.33 |
PVD | 3 (16%) | 0 (0%) | 0.08 |
Previous MI | 4 (21%) | 6 (31.5%) | 0.42 |
LVEF | 48 ± 10 | 46 ± 10 | 0.49 |
Euroscore | 2.3 ± 1.7 | 2.5 ± 1.6 | 0.58 |
Values are means ± SD or No.(%) where shown.
M/F: Male/Female
Wt.: Weight
BMI: Body Mass Index
COPD: Chronic Obstructive Pulmonary Disease
RF: Renal Failure
Hyperchol: Hypercholesterolmia
PVD: Peripheral Vascular Disease
MI: Myocardial Infarction
LVEF: Left Ventricular Ejection Fraction